Cargando…

Employing nanobodies for immune landscape profiling by PET imaging in mice

Noninvasive immunoimaging holds great potential for studying and stratifying disease as well as therapeutic efficacy. Radiolabeled single-domain antibody fragments (i.e., nanobodies) are appealing probes for immune landscape profiling, as they display high stability, rapid targeting, and excellent s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teunissen, Abraham J.P., Abousaway, Omar B., Munitz, Jazz, van Leent, Mandy M.T., Toner, Yohana C., Priem, Bram, Senders, Max L., Pérez-Medina, Carlos, Mulder, Willem J.M., Rashidian, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056265/ https://www.ncbi.nlm.nih.gov/pubmed/33899016 http://dx.doi.org/10.1016/j.xpro.2021.100434

Ejemplares similares

In vivo imaging of cerebral glucose metabolism informs on subacute to chronic post-stroke tissue status – A pilot study combining PET and deuterium metabolic imaging
por: Meerwaldt, Anu E, et al.
Publicado: (2023)

Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models
por: Maier, Alexander, et al.
Publicado: (2023)

Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation
por: Toner, Yohana C., et al.
Publicado: (2022)

Nanobodies for Medical Imaging: About Ready for Prime Time?
por: Berland, Léa, et al.
Publicado: (2021)

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
por: Senders, Max L., et al.
Publicado: (2018)

Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells
por: Schrijver, David P., et al.
Publicado: (2023)

Nanobodies as non-invasive imaging tools
por: Rashidian, M., et al.
Publicado: (2020)

A modular approach toward producing nanotherapeutics targeting the innate immune system
por: van Leent, Mandy M. T., et al.
Publicado: (2021)

Tumor Targeting by α(v)β(3)-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
por: Sofias, Alexandros Marios, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)

Noninvasive Imaging of Cancer Immunotherapy
por: Abousaway, Omar, et al.
Publicado: (2021)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Emergency-aid for self-employed in the Covid-19 pandemic: A flash in the pan?()
por: Block, Joern, et al.
Publicado: (2022)

Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
por: Feng, Xuemei, et al.
Publicado: (2023)

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
por: Lameijer, Marnix, et al.
Publicado: (2018)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Special Issue: Nanobody
por: Chames, Patrick, et al.
Publicado: (2020)

Immuno-targeting the multifunctional CD38 using nanobody
por: Li, Ting, et al.
Publicado: (2016)

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
por: van Brussel, Aram S. A., et al.
Publicado: (2015)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
por: Poels, Kikkie, et al.
Publicado: (2020)

Nanobody-Displaying Flagellar Nanotubes
por: Klein, Ágnes, et al.
Publicado: (2018)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021)

Structure of Nanobody Nb23
por: Percipalle, Mathias, et al.
Publicado: (2021)

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

Applications of nanobodies in brain diseases
por: Zheng, Fang, et al.
Publicado: (2022)

Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
por: Zuo, Jing, et al.
Publicado: (2017)

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

Hybrid PET/MR Kernelised Expectation Maximisation Reconstruction for Improved Image-Derived Estimation of the Input Function from the Aorta of Rabbits
por: Deidda, Daniel, et al.
Publicado: (2019)

Optimizing expression of Nanobody® molecules in Pichia pastoris through co-expression of auxiliary proteins under methanol and methanol-free conditions
por: De Groeve, Manu, et al.
Publicado: (2023)

Nanobody: The “Magic Bullet” for Molecular Imaging?
por: Chakravarty, Rubel, et al.
Publicado: (2014)

Nanobodies and recombinant binders in cell biology
por: Helma, Jonas, et al.
Publicado: (2015)

Nanobody Based Dual Specific CARs
por: De Munter, Stijn, et al.
Publicado: (2018)

Nanobodies—Useful Tools for Allergy Treatment?
por: Flicker, Sabine, et al.
Publicado: (2020)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p2fts61fkovjhchv6mulbf17rc